ATE243993T1 - Verwendung von 5ht3 antagonisten zum fördern der darmspülung - Google Patents

Verwendung von 5ht3 antagonisten zum fördern der darmspülung

Info

Publication number
ATE243993T1
ATE243993T1 AT98922759T AT98922759T ATE243993T1 AT E243993 T1 ATE243993 T1 AT E243993T1 AT 98922759 T AT98922759 T AT 98922759T AT 98922759 T AT98922759 T AT 98922759T AT E243993 T1 ATE243993 T1 AT E243993T1
Authority
AT
Austria
Prior art keywords
antagonists
flushment
promote intestinal
intestinal
promote
Prior art date
Application number
AT98922759T
Other languages
English (en)
Inventor
Antonius Adrianus Hendr Megens
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of ATE243993T1 publication Critical patent/ATE243993T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
AT98922759T 1997-04-18 1998-04-14 Verwendung von 5ht3 antagonisten zum fördern der darmspülung ATE243993T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97201149 1997-04-18
PCT/EP1998/002356 WO1998047481A1 (en) 1997-04-18 1998-04-14 Use of 5ht3 antagonists for promoting intestinal lavage

Publications (1)

Publication Number Publication Date
ATE243993T1 true ATE243993T1 (de) 2003-07-15

Family

ID=8228223

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98922759T ATE243993T1 (de) 1997-04-18 1998-04-14 Verwendung von 5ht3 antagonisten zum fördern der darmspülung

Country Status (12)

Country Link
US (2) US6235745B1 (de)
EP (1) EP0975327B1 (de)
JP (1) JP2001523239A (de)
KR (1) KR100529512B1 (de)
AT (1) ATE243993T1 (de)
AU (1) AU745361B2 (de)
CA (1) CA2286076C (de)
DE (1) DE69816060T2 (de)
DK (1) DK0975327T3 (de)
ES (1) ES2202855T3 (de)
PT (1) PT975327E (de)
WO (1) WO1998047481A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1090638A1 (de) * 1999-10-08 2001-04-11 Sanofi-Synthelabo Verwendung von (R)-Zacopride oder dessen Salz zur Herstellung eines Medikaments für die Behandlung von Schlafapnoe
EP1347779A2 (de) * 2000-11-24 2003-10-01 Janssen Pharmaceutica N.V. Verwendung einer dreifach-kombination mit einem 5ht3-antagonisten, einem 5ht4-agonisten und einem laxativum zur förderung der darmspülung
PE20021019A1 (es) 2001-04-19 2002-11-13 Upjohn Co Grupos azabiciclicos sustituidos
GB0216027D0 (en) * 2002-07-10 2002-08-21 Arachnova Therapeutics Ltd New therapeutic use
US20040048874A1 (en) * 2001-05-22 2004-03-11 Bardsley Hazel Judith New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D]pyrimidine
TWI332943B (en) * 2001-07-10 2010-11-11 Synta Pharmaceuticals Corp Taxol enhancer compounds
RU2229882C2 (ru) * 2002-04-05 2004-06-10 Научно-производственный центр "Фармзащита" Лекарственное средство
US6946149B2 (en) * 2002-04-30 2005-09-20 Braintree Laboratories, Inc. Salt solution for colon cleansing
AU2003272740A1 (en) * 2002-10-01 2004-04-23 Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 4,6-diaminosubstituted-2-[oxy or aminoxy]-[1,3,5]triazines as protein tyrosine kinase inhibitors
US6996500B2 (en) * 2002-10-30 2006-02-07 Hewlett-Packard Development Company, L.P. Method for communicating diagnostic data
JP2006516977A (ja) * 2003-01-13 2006-07-13 ダイノゲン ファーマシューティカルズ，インコーポレイテッド 悪心、嘔吐、レッチング、またはそれらの任意の組み合わせの治療方法
PL378367A1 (pl) * 2003-01-13 2006-04-03 Dynogen Pharmaceuticals, Inc. Sposób leczenia czynnościowych zaburzeń jelit
US6846823B2 (en) 2003-04-04 2005-01-25 Dynogen Pharmaceuticals, Inc. Method of treating lower urinary tract disorders
US7049319B2 (en) * 2003-09-23 2006-05-23 Semaan Abboud Colon cleansing composition and method
WO2005099698A1 (ja) * 2004-04-15 2005-10-27 Eisai R & D Management Co., Ltd. 安定化された４－アミノ－５－クロロ－Ｎ－［（１Ｒ，３ｒ，５Ｓ）－８－メチル－８－アザビシクロ［３．２．１］オクタ－３－イル]－２－［１－メチルブタ－２－インイルオキシ］ベンズアミド含有組成物
US20060293309A1 (en) * 2005-03-28 2006-12-28 Dynogen Pharmaceuticals, Inc. Method of treating disorders and conditions using peripherally-restricted antagonists and inhibitors
WO2007019888A2 (en) * 2005-08-12 2007-02-22 Ctg Pharma S.R.L. Therapeutic compositions containing mesalamine and a co-agent for treating colon diseases
AU2006279891B2 (en) * 2005-08-16 2010-03-11 Synta Pharmaceuticals Corp. Bis(thio-hydrazide amide) formulation
WO2007025177A2 (en) * 2005-08-26 2007-03-01 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
WO2008019363A2 (en) 2006-08-07 2008-02-14 Albany Molecular Research, Inc. 2-alkylbenzoxazole carboxamides as 5ht3 modulators
JP5512268B2 (ja) * 2006-08-07 2014-06-04 アルバニー モルキュラー リサーチ，インコーポレイテッド ５ｈｔ３モジュレーターとしての２−アミノベンゾオキサゾールカルボキサミド
US9545446B2 (en) 2013-02-25 2017-01-17 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
EP3563838A1 (de) 2013-03-15 2019-11-06 Braintree Laboratories, Inc. Doppelt verwendbare orale tabletten einer pharmazeutischen zusammensetzung aus sulfatsalzen und verfahren zur verwendung davon
US10172833B2 (en) 2015-08-11 2019-01-08 Insys Development Company, Inc. Sublingual ondansetron spray
US10143656B1 (en) 2017-08-04 2018-12-04 Braintree Laboratories, Inc. Solid oral sulfate salt formulations for cleaning a colon and methods of using same
WO2020067456A1 (ja) * 2018-09-28 2020-04-02 武田薬品工業株式会社 複素環化合物
US12239659B2 (en) 2023-06-15 2025-03-04 Braintree Laboratories, Inc. Methods of administering safe colon cleansing compositions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB893267A (en) 1958-11-25 1962-04-04 Sterling Drug Inc Laxative enemas
US5166145A (en) * 1990-09-10 1992-11-24 Alza Corporation Antiemetic therapy
TW294595B (de) 1992-11-20 1997-01-01 Janssen Pharmaceutica Nv
US6103734A (en) 1994-11-04 2000-08-15 Legarda Ibanez; Juan Jose Drug combination as a medicament to suppress the dependence of individuals to opiates
WO1996014071A1 (es) 1994-11-04 1996-05-17 Legarda Ibanez Juan Jose Combinacion de farmacos como medicamento destinado a supresion de dependencia de individuos a opiaceos
US5576317A (en) * 1994-12-09 1996-11-19 Pfizer Inc. NK-1 receptor antagonists and 5HT3 receptor antagonists for the treatment of emesis

Also Published As

Publication number Publication date
JP2001523239A (ja) 2001-11-20
CA2286076C (en) 2006-12-12
AU745361B2 (en) 2002-03-21
DK0975327T3 (da) 2003-10-20
DE69816060T2 (de) 2004-04-22
DE69816060D1 (de) 2003-08-07
US6235745B1 (en) 2001-05-22
KR20000075858A (ko) 2000-12-26
US6555546B2 (en) 2003-04-29
EP0975327B1 (de) 2003-07-02
WO1998047481A1 (en) 1998-10-29
CA2286076A1 (en) 1998-10-29
AU7528298A (en) 1998-11-13
EP0975327A1 (de) 2000-02-02
KR100529512B1 (ko) 2005-11-22
ES2202855T3 (es) 2004-04-01
PT975327E (pt) 2003-11-28
US20010020025A1 (en) 2001-09-06

Similar Documents

Publication Publication Date Title
ATE243993T1 (de) Verwendung von 5ht3 antagonisten zum fördern der darmspülung
DE69819311D1 (de) Neue benzimidazol inhibitoren der fructose-1,6-bisphosphatase
TR200000782T2 (tr) Resorsinol türevleri.
FI964004A0 (fi) Serotoniiniantagonistien (5HT3) käyttö fibromyalgian hoitoon
PT892780E (pt) Analogos de m-amidino fenilo como inibidores do factor xa
CU22997A3 (es) Proteína híbrida para la inhibición de la desgranulación de los mastocitos y su utilización
BR9810342A (pt) Novos compostos imidazola substituìdos
SE9702773D0 (sv) Novel compounds
NO20006166L (no) Brodannede indenopyrrolokarbazoler
EA199900630A1 (ru) Антагонисты рецепторов витронектина
AR016981A2 (es) Polipeptidos sinteticos
TR200002896T2 (tr) Kalsilitik Bileşimler
EA200000536A1 (ru) Применение комбинации ингибитора конвертирующего фермента и диуретика для лечения нарушений микроциркуляции
DE3866309D1 (de) Laktonmodifizierte mannich-basen als dispergier-zusaetze, verwendbar in oeligen zusammensetzungen.
TR200102742T2 (tr) Rezorsinol türevleri
EA200100517A1 (ru) Антагонисты 5ht1 для антидепрессантной терапии
PT696194E (pt) Utilizacao de derivados de indole como antagonistas de 5ht1
FI972684L (fi) Piperidiinietikkahappojohdannaisia, joita voidaan käyttää fibrinogeeniantagonisteina
NO882054L (no) Sementblanding, saerlig til bruk i borehull.
EA200100854A1 (ru) Кальций-литические соединения
DE3873278D1 (de) Aryl-substituierte thiophen-3-ole, ihre derivate und analoge als lipoxygenase-inhibitoren.
TR200001080T2 (tr) 2 ile ikame edilmiş 1,2-Benisotiyazol türevleri ve bunların serrotonın antagonistleri
TR200003203T2 (tr) Karboksaldehitin saflaştırılması
PE20399A1 (es) Muteina ob
ATE213236T1 (de) Substituierte benzyloxyimino-verbindungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0975327

Country of ref document: EP

REN Ceased due to non-payment of the annual fee